ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE): $264M Department of Health and Human Services Contract
Summary
The Department of Health and Human Services awarded a $264M definitive contract to the private Albert B. Sabin Vaccine Institute for Marburg virus vaccine R&D and procurement over a 10-year period. This award reinforces federal commitment to biodefense but has no direct public company exposure.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $264M Marburg vaccine contract is a significant biodefense award but goes to a private entity, limiting direct stock market implications.
- 2.The 10-year duration underscores long-term government commitment to medical countermeasure preparedness.
- 3.Investors should monitor broader biodefense spending trends rather than specific tickers from this award.
Market Implications
This contract does not directly move any public company's stock because the recipient is private. However, it adds to the narrative of increased government spending on pandemic preparedness, which may support valuations of publicly traded vaccine developers like Moderna ($MRNA) or Pfizer ($PFE) over the long term, though no immediate revenue impact is attributable. The contract's size ($264M over 10 years) is modest relative to the overall biopharma market, so sector-level effects are muted.
⚡ Government Convergence
Active government convergence in this signal’s sector right now.
Over the last 90 days, 35 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 26 federal contracts, 8 procurement notices and 1 bills — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-07
- ContractGLAXOSMITHKLINE, LLC: $27.3M Department of Health and Human Services Contract · 2026-08-18
- ContractSTRING KING LACROSSE LLC: $95.9M Department of Health and Human Services Contract · 2026-08-19
- ContractSANOFI PASTEUR VAXDESIGN CORP: TAS::75 0140::TAS CLINICAL TRIAL IN A TEST TUBE FOR MEDICAL COUNTERMEASURE DEVELOPMENT · 2026-08-19
Full Analysis
The contract, titled 'Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP),' was awarded by the Office of Assistant Secretary for Preparedness and Response (ASPR) to the Albert B. Sabin Vaccine Institute, a private nonprofit focused on vaccine development. The $264M award spans from May 2026 to April 2036, indicating a long-term government investment in Marburg virus countermeasures. As the recipient is not publicly traded, there is no direct equity impact on listed companies. However, this contract signals sustained federal prioritization of biodefense and pandemic preparedness, which benefits the broader healthcare sector involved in vaccine and therapeutic development. While no specific public companies are named, the contract may indirectly support demand for contract research organizations, raw material suppliers, and manufacturing partners, though these are not explicitly identified in the award. The absence of directly related legislation among the provided bill signals suggests this funding stems from existing appropriations rather than new authorization. Historically, large biodefense contracts like this one reinforce the government's role as a stable, multi-year customer for vaccine developers, but without a public company recipient, the market impact is diffuse.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
HUMAN SERVICES, NEW JERSEY DEPARTMENT OF: $16.9B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
DEPARTMENT OF SOCIAL SERVICES MISSO: $15.1B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $14.1B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
Award Amount
$263,613,186
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →